Completed
Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
NCT03912259
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Investigational Site Number 1560019 Beijing, China
- Investigational Site Number 1560001 Beijing, China
- Investigational Site Number 1560004 Beijing, China
- Investigational Site Number 1560003 Beijing, China